Simplex Trading’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,400
| Closed | -$161K | – | 8396 |
|
|
2025
Q3 | $161K | Sell |
3,400
-19,400
| -85% | -$939K | ﹤0.01% | 5191 |
|
|
2025
Q2 | $1.22M | Sell |
22,800
-55,000
| -71% | -$2.5M | ﹤0.01% | 2582 |
|
|
2025
Q1 | $3.15M | Buy |
77,800
+12,000
| +18% | +$509K | ﹤0.01% | 1619 |
|
|
2024
Q4 | $1.83M | Buy |
65,800
+43,900
| +200% | +$1.33M | ﹤0.01% | 2267 |
|
|
2024
Q3 | $628K | Sell |
21,900
-2,900
| -12% | -$75.6K | ﹤0.01% | 3346 |
|
|
2024
Q2 | $581K | Sell |
24,800
-14,300
| -37% | -$306K | ﹤0.01% | 3502 |
|
|
2024
Q1 | $987K | Buy |
39,100
+29,700
| +316% | +$713K | ﹤0.01% | 3134 |
|
|
2023
Q4 | $219K | Sell |
9,400
-63,000
| -87% | -$1.24M | ﹤0.01% | 4582 |
|
|
2023
Q3 | $3.66M | Buy |
72,400
+17,700
| +32% | +$824K | ﹤0.01% | 1559 |
|
|
2023
Q2 | $2.55M | Buy |
54,700
+39,500
| +260% | +$1.81M | ﹤0.01% | 1777 |
|
|
2023
Q1 | $581K | Sell |
15,200
-31,100
| -67% | -$1.39M | ﹤0.01% | 3113 |
|
|
2022
Q4 | $2.54M | Sell |
46,300
-69,100
| -60% | -$2.96M | ﹤0.01% | 1691 |
|
|
2022
Q3 | $3.93M | Buy |
115,400
+110,600
| +2,304% | +$1.69M | ﹤0.01% | 1374 |
|
|
2022
Q2 | $45K | Buy |
4,800
+4,700
| +4,700% | +$49K | ﹤0.01% | 6628 |
|
|
2022
Q1 | $1K | Sell |
100
-100
| -50% | -$1.75K | ﹤0.01% | 10021 |
|
|
2021
Q4 | $4K | Sell |
200
-16,100
| -99% | -$357K | ﹤0.01% | 9634 |
|
|
2021
Q3 | $413K | Hold |
16,300
| – | – | ﹤0.01% | 4384 |
|
|
2021
Q2 | $404K | Buy |
16,300
+14,702
| +920% | +$413K | ﹤0.01% | 4487 |
|
|
2021
Q1 | $4.63M | Buy |
+1,598
| New | +$48.4K | 0.01% | 884 |
|
|
2020
Q3 | – | Sell |
-2
| Closed | -$4K | – | 7704 |
|
|
2020
Q2 | $4K | Hold |
2
| – | – | ﹤0.01% | 7033 |
|
|
2020
Q1 | $4K | Buy |
+2
| New | +$43 | ﹤0.01% | 6922 |
|
Other funds holding AKRO
Simplex Trading's AKRO Position: Q4 2025 in Review
Simplex Trading sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4,565 shares — an estimated $216K sold.
Simplex Trading first reported a position in AKRO in Q2 2020 and held it in 15 quarters. The position peaked at $2.67M in Q3 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Simplex Trading reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 4,565 Akero Therapeutics shares in Q4 2025, an estimated $216K.
- Simplex Trading first reported a position in Akero Therapeutics in Q2 2020 and held it in 15 quarters.
- Simplex Trading's Akero Therapeutics position peaked at $2.67M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.